Abstract
The prevalence of peripheral arterial disease and both traditional and nontraditional vascular risk factors are more common in patients with end-stage renal disease who are undergoing hemodialysis than the general population. Patients undergoing hemodialysis may also be at risk for peripheral arterial disease via nonvascular risk factors and the hemodialysis treatment itself. Unfortunately, because peripheral arterial disease and its risk factors in hemodialysis patients have not been thoroughly ascertained, evaluation of potential treatments has been limited. Given the high potential of morbidity and impaired quality-of-life related to peripheral arterial disease in patients with end-stage renal disease, additional studies are needed to evaluate both quality of life and potential screening for peripheral arterial disease, its risk factors, and treatments to identify areas for improvement in this vulnerable population.
Original language | English (US) |
---|---|
Pages (from-to) | 108-111 |
Number of pages | 4 |
Journal | Methodist DeBakey cardiovascular journal |
Volume | 9 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2013 |
ASJC Scopus subject areas
- General Medicine